Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Neurophage Pharmaceuticals

Neurophage Pharmaceuticals

A company developing fusion-protein drug therapies to treat chronic neurodegenerative diseases, amyloidoses, Alzheimer’s and Parkinson’s diseases

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 24 May, 2023
"Clean up website values by canonicalizing and removing duplicates"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
http://www.neurophage.com
Edits on 5 May, 2023
"Covert AngelList URL to Wellfound ID"
Golden AI profile picture
Golden AI
edited on 5 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Wellfound ID
neurophage-pharmaceuticals
Edits on 16 Mar, 2023
"prospector:2472:2542305"
Katrina-Kay Pettitt profile picture
Katrina-Kay Pettitt
edited on 16 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Biology
Biology
"prospector:2473:2553486"
Katrina-Kay Pettitt profile picture
Katrina-Kay Pettitt
edited on 16 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Biotechnology
Biotechnology
Edits on 23 Feb, 2023
"prospector:2317:2481205"
Katrina-Kay Pettitt profile picture
Katrina-Kay Pettitt
edited on 23 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Technology
Technology
Edits on 10 Aug, 2022
"Goldmine dedupe task response id: 1867443"
Wyckliffe Otieno profile picture
Wyckliffe Otieno
edited on 10 Aug, 2022
Edits made to:
Infobox (+9 properties)
Article
Article

Infobox
Legal name
NeuroPhage Pharmaceuticals, Inc.
Country
United States
United States
Founded date
January 1, 2006
Full address
85 Bolton St, Cambridge, MA 02140, US
Industry
Neuroscience
Neuroscience
Consumer biotechnology
Consumer biotechnology
Number of Employees (ranges)
10 – 19
Official Website
http://neurophage.com
Edits on 8 Aug, 2022
"official website closed"
Andrey Duzenko profile picture
Andrey Duzenko
edited on 8 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Closed
Edits on 16 May, 2022
"prospector:1525:714592"
Katrina-Kay Pettitt profile picture
Katrina-Kay Pettitt
edited on 16 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Organization
Organization
Edits on 6 Aug, 2021
"Inferring industry - ai.industry_clf.02"
Golden AI profile picture
Golden AI
edited on 6 Aug, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Edits on 12 May, 2021
"Funding autocalculation"
Golden AI profile picture
Golden AI
edited on 12 May, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding type
Series D
Series D
Edits on 28 Mar, 2021
"Found on funding round"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2021
Edits made to:
Infobox (+2 properties)
Infobox
Investors
Shire (pharmaceutical company)
Shire (pharmaceutical company)
Merieux Equity Partners
Merieux Equity Partners
Edits on 6 Oct, 2020
"Funding autocalculation"
Golden AI profile picture
Golden AI
edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
March 2014
Edits on 17 Jul, 2020
"Funding autocalculation"
Golden AI profile picture
Golden AI
edited on 17 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
17,000,000
Edits on 28 Feb, 2020
Golden AI profile picture
Golden AI
edited on 28 Feb, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
‌
Neurophage Pharmaceuticals Series D round March 2014
Edits on 21 Jan, 2019
"Changed markets to industries"
Golden AI profile picture
Golden AI
edited on 21 Jan, 2019
Edits made to:
Infobox (+1/-1 properties)
Infobox
Market
Industry
Edits on 10 Jan, 2019
Golden AI profile picture
Golden AI
edited on 10 Jan, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Company
Edits on 12 Dec, 2018
"Import data"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2018
Edits made to:
Infobox (+4 properties)
Table (+3 rows) (+6 cells) (+73 characters)
Categories (+1 topics)
Table

Name
Role
Related Golden topics

Alfonso von Wunschheim

Investor

Evan Schwartz

Employee

Manuel Roumain

Investor

Infobox
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
AngelList
https://angel.co/neurophage-pharmaceuticals
LinkedIn
http://www.linkedin.com/groups/NeuroPhage-Pharmaceuticals-5071175/about
Market
Edits on 19 Jul, 2018
"Update locations in infobox"
Golden AI profile picture
Golden AI
edited on 19 Jul, 2018
Edits on 29 Jun, 2018
"Update infobox"
Golden AI profile picture
Golden AI
edited on 29 Jun, 2018
Edits on 18 Jun, 2018
"Updating description"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2018
Edits made to:
Description (+145/-21 characters)
Topic thumbnail

Neurophage Pharmaceuticals

Biotechnology company

A company developing fusion-protein drug therapies to treat chronic neurodegenerative diseases, amyloidoses, Alzheimer’s and Parkinson’s diseases

Find more companies like Neurophage Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.